List of SBIR/STTR awards granted to MAX BioPharma

List of SBIR/STTR awards granted to MAX BioPharma

List of SBIR/STTR awards granted to PGI HOLDING CORPORATION

List of SBIR/STTR awards granted to Ceracom, Inc.

List of SBIR/STTR awards granted to Laser Operations LLC

Investment funds in Stockholm County

List of awards received by Ken Burns

where

SBIR/STTR Award Recipient

is

MAX BioPharma

	Name	Description	SBIR/STTR Award Recipient	Government Agency	Government Branch	Award Type	Contract Number (US Government)	Award Phase	Award Amount (USD)	Date Awarded	Official Website
	‌ Max Biopharma, Inc. SBIR Phase II Award, September 2021	A SBIR Phase II contract was awarded to MAX BioPharma in September, 2021 for $855,153.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	MAX BioPharma		National Institutes of Health	SBIR	1R44AR079335-01	Phase II	855,153	September 1, 2021	sbir.gov/node/2188041
	‌ Max Biopharma, Inc. SBIR Phase II Award, September 2018	A SBIR Phase II contract was awarded to MAX BioPharma in September, 2018 for $1,950,018.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	MAX BioPharma		National Institutes of Health	SBIR	2R44AG055374-04	Phase II	1,950,018	September 30, 2018	sbir.gov/node/1569859
	‌ Max Biopharma, Inc. SBIR Phase I Award, August 2020	A SBIR Phase I contract was awarded to MAX BioPharma in August, 2020 for $223,696.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	MAX BioPharma		National Institutes of Health	SBIR	1R43DK125139-01A1	Phase I	223,696	August 21, 2020	sbir.gov/node/1913917
	‌ Max Biopharma, Inc. SBIR Phase I Award, May 2022	A SBIR Phase I contract was awarded to MAX BioPharma in May, 2022 for $320,724.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	MAX BioPharma		National Institutes of Health	SBIR	1R43HL162245-01A1	Phase I	320,724	May 23, 2022	sbir.gov/node/2337581
	‌ Max Biopharma, Inc. SBIR Phase I Award, August 2022	A SBIR Phase I contract was awarded to MAX BioPharma in August, 2022 for $318,089.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	MAX BioPharma		National Institutes of Health	SBIR	1R43HL165998-01	Phase I	318,089	August 10, 2022	sbir.gov/node/2340211
	‌ Max Biopharma, Inc. SBIR Phase II Award, September 2016	A SBIR Phase II contract was awarded to MAX BioPharma in September, 2016 for $998,650.0 USD from the U.S. Department of Health & Human Services.	MAX BioPharma			SBIR	9R44AG055374-02	Phase II	998,650	September 15, 2016	sbir.gov/node/1198059
	‌ Max Biopharma, Inc. SBIR Phase II Award, March 2016	A SBIR Phase II contract was awarded to MAX BioPharma in March, 2016 for $899,267.0 USD from the U.S. Department of Health & Human Services.	MAX BioPharma			SBIR	2R44AR065148-02A1	Phase II	899,267	March 17, 2016	sbir.gov/node/1164915
	‌ Max Biopharma, Inc. SBIR Phase I Award,	A SBIR Phase I contract was awarded to MAX BioPharma for $147,188.0 USD from the U.S. Department of Health & Human Services.	MAX BioPharma			SBIR	1R43AR065148-01	Phase I	147,188		sbir.gov/node/677572
	‌ Max Biopharma, Inc. SBIR Phase I Award,	A SBIR Phase I contract was awarded to MAX BioPharma for $149,342.0 USD from the U.S. Department of Health & Human Services.	MAX BioPharma			SBIR	1R43AR065808-01A1	Phase I	149,342		sbir.gov/node/705245
	‌ Max Biopharma, Inc. SBIR Phase II Award, May 2023	A SBIR Phase II contract was awarded to MAX BioPharma in May, 2023 for $896,990.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	MAX BioPharma		National Institutes of Health	SBIR	1R44DK136405-01	Phase II	896,990	May 1, 2023	sbir.gov/node/2509647

10 results

0 selected

10 results

0 selected